Literature DB >> 8877861

Comparison of liquid chromatography, capillary electrophoresis and super-critical fluid chromatography in the determination of Losartan Potassium drug substance in Cozaar tablets.

R C Williams1, M S Alasandro, V L Fasone, R J Boucher, J F Edwards.   

Abstract

Reversed phase liquid chromatography, micellar electrokinetic chromatography, and packed column supercritical fluid chromatography were used to measure the amount of Losartan Potassium drug substance in pharmaceutical tablets. Tablet extract samples were analyzed and results were used to compare accuracy, precision, and linearity of calibration of the instrumental techniques. All three techniques have satisfactory precision (less than 1% RSD) and accuracy to be used for the analysis of the drug substance in tablets and the advantages of each technique are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877861     DOI: 10.1016/0731-7085(96)01740-2

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Development of a membrane-less dynamic field gradient focusing device for the separation of low-molecular-weight molecules.

Authors:  Jeffrey M Burke; Colin D Smith; Cornelius F Ivory
Journal:  Electrophoresis       Date:  2010-03       Impact factor: 3.535

2.  RP-HPLC Method for the Determination of Losartan Potassium and Ramipril in Combined Dosage Form.

Authors:  K Srinivasa Rao; K Srinivas
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

3.  Novel and validated titrimetric method for determination of selected angiotensin-II-receptor antagonists in pharmaceutical preparations and its comparison with UV spectrophotometric determination.

Authors:  Shrikant H Patil; Minakshi V Janjale
Journal:  J Pharm Anal       Date:  2012-04-09

4.  Stability-indicating Reversed-phase Liquid Chromatographic Method for Simultaneous Determination of Losartan Potassium and Ramipril in Tablets.

Authors:  S Kollipara; G Bende; Y Bansal; R Saha
Journal:  Indian J Pharm Sci       Date:  2012-05       Impact factor: 0.975

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.